Is Medicenna Therapeutics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Medicenna Therapeutics Corp (MDNA.TO) is currently classified as NOT HALAL as of April 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Medicenna Therapeutics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medicenna Therapeutics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Medicenna Therapeutics Corp?

Muslim investors may consider investing in Medicenna Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Medicenna Therapeutics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Medicenna Therapeutics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Medicenna Therapeutics Corp updated?

The Shariah compliance status of Medicenna Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Medicenna Therapeutics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Medicenna Therapeutics Corp?

You can check the latest Shariah compliance status of Medicenna Therapeutics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MDNA.TO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 08, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for Medicenna Therapeutics Corp (MDNA.TO)

Based on 10 analysts giving stock ratings to Medicenna Therapeutics Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Medicenna Therapeutics Corp. Stock Analysis MDNA.TO

Canada Health Care Nano Cap Report: Q3, 2025

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. The company is headquartered in Toronto, Ontario and currently employs 18 full-time employees. The company went IPO on 2015-07-13. Its long-acting IL-2 Superkine, MDNA11, is a IL-2 with superior affinity toward CD122 (IL-2 receptor beta) and no CD25 (IL-2 receptor alpha) binding, thereby preferentially stimulating cancer-killing effector T cells and NK cells. Its IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials, including a Phase IIb trial for recurrent glioblastoma (GBM). Its early-stage high-affinity IL-2B biased IL-2/IL-15 Super-antagonists, from its MDNA209 platform, are being evaluated as potential therapies for autoimmune and graft-versus host diseases. Its early-stage BiSKITs (Bifunctional SuperKine ImmunoTherapies) and the T-MASK (Targeted Metalloprotease Activated SuperKine) programs are designed to enhance the ability of Superkines to treat immunologically cold tumors.

Key Statistics of Medicenna Therapeutics Corp (MDNA.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.54CAD0.57

Today's Open

CAD0.57

Volume

56.74K

P/E Ratio (TTM)

52 Week Range

CAD0.51CAD1.97

Market Cap

42.61M

Avg. Volume

136.31K

Dividend Yield

Financial Metrics & Statements of Medicenna Therapeutics Corp (MDNA.TO)

FAQ's for Medicenna Therapeutics Corp (MDNA.TO)

According to Musaffa’s Shariah screening methodology, Medicenna Therapeutics Corp (MDNA.TO) is currently classified as NOT HALAL as of April 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.